IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1466 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5230    
    Printed83    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL CONTRIBUTIONS
Year : 1990  |  Volume : 56  |  Issue : 3  |  Page : 204--207

An open comparlson of mupirocln and oxyteracycline for the therapy of skin infections



Correspondence Address:
Vinay Kulkarni


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Mupirocin (pseudomonic acid) is a new antibacterial compound active against a wide range of organisms responsible for skin and soft tissue infections. It is bactericidal at concentrations achieved following topical application. An open comparative study was carried out to assess the clinical and bacteriological effectiveness of 2% muhirocin as compared to 3% oxytertracycline by topical application in a variety of primary and secondary skin infections. Fifty patients were included in each age and sex matched group. The overall efficacy of mupirocin was 92% compared to 80% of oxytetracycline. Mupirocin was especially effective in cases of impetigo, 75% cases being cured and 25% showing good improvement at the end of 12 days. With oxytetracycline the figures were 40% cured and 33.3% showing good response. The speed of recovery with mupirocin was faster than with oxytetracycline.






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow